Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
915.2 ILa | +0.59% | -16.19% | +97.62% |
May. 01 | InterCure Ltd. Provides Revenue Guidance for the Full Year 2024 | CI |
May. 01 | InterCure Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2022 | 388.68 144K | Sales 2023 | 355.55 132K | Capitalization | 211M 78.16B |
---|---|---|---|---|---|
Net income 2022 | 44M 16.3B | Net income 2023 | -62M -22.96B | EV / Sales 2022 | 1,473,908 x |
Net Debt 2022 | 22.37M 8.28B | Net Debt 2023 | 94.35M 34.94B | EV / Sales 2023 | 858,938 x |
P/E ratio 2022 |
12.2
x | P/E ratio 2023 |
-3.41
x | Employees | 270 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 60.24% |
1 day | +0.59% | ||
1 week | -16.19% | ||
Current month | -18.07% | ||
1 month | -25.29% | ||
3 months | +39.30% | ||
6 months | +86.78% | ||
Current year | +97.62% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 53 | 18-09-30 | |
Amos Cohen
DFI | Director of Finance/CFO | 45 | 20-02-29 |
Yisrael Gewirtz
AUD | Comptroller/Controller/Auditor | 47 | 13-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ehud Barak
CHM | Chairman | 81 | 18-08-31 |
Chief Executive Officer | 53 | 18-09-30 | |
Director/Board Member | 63 | 20-10-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
13.29% | 3 M€ | -35.65% | - | |
0.13% | 13 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 915.2 | +0.59% | 72,652 |
24-06-09 | 909.8 | +0.15% | 54,135 |
24-06-06 | 908.4 | -5.45% | 150,107 |
24-06-05 | 960.8 | -8.06% | 216,739 |
24-06-04 | 1,045 | -4.30% | 126,278 |
Delayed Quote TEL AVIV STOCK EXCHANGE, June 10, 2024 at 10:24 am EDT
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+97.62% | 111M | |
+21.40% | 228M | |
+1.03% | 213M | |
+27.33% | 165M | |
+26.09% | 116M | |
-55.51% | 99.84M | |
+100.00% | 90.39M | |
-7.69% | 86.46M | |
+88.89% | 50.92M |
- Stock Market
- Equities
- INCR Stock